CD8A and cytomegalovirus infection: Although the QuantiFERON-CMV® assay is primarily designed to assess the CD8+ T cell responses, it is important to mention here that a number of groups have highlighted the importance of both CD8+ and CD4+ T cells in controlling CMV infection and disease in both allogeneic HSCT and solid organ transplant recipients.